The novel focal adhesion gene kindlin-2 promotes the invasion of gastric cancer cells mediated by tumor-associated macrophages

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 791-797

  Shen, Zhanlong ^a,b   Ye, Yingjiang ^a   Kauttu, Tuuli ^b   Seppänen, Hanna ^b   Vainionpää, Sanna ^b   Wang, Shan ^a   Mustonen, Harri ^b   Puolakkainen, Pauli ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gastric cancer; Interleukin; Invasion; Kindlin 2; Tumor associated macrophages

Indexed keywords

FOCAL ADHESION KINASE; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 17; INTERLEUKIN 17B; INTERLEUKIN 18; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 8; KINDLIN 2 PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL HYPOXIA; CELL INVASION; CELL LEVEL; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KINDLIN 2 GENE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION;

ANOXIA; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; DOWN-REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKINS; MACROPHAGES; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84872788127     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2137     Document Type: Article

References (35)

1. Rogalski TM, Mullen GP, Gilbert MM, Williams BD and Moerman DG: The UNC-112 gene in Caenorhabditis elegans encodes a novel component of cell-matrix adhesion structures required for integrin localization in the muscle cell membrane. J Cell Biol 150: 253-264, 2000. (Pubitemid 30480998)
2. Wegener KL, Partridge AW, Han J, et al: Structural basis of integrin activation by talin. Cell 128: 171-182, 2007. (Pubitemid 46048890)
3. Ussar S, Wang H V, Linder S, Fässler R and Moser M: The Kindlins: subcellular localization and expression during murine development. Exp Cell Res 312: 42-51, 2006.
4. Shi X, Ma YQ, Tu Y, et al: The MIG-2/integrin interaction strengthens cell-matrix adhesion and modulates cell motility. J Biol Chem 282: 20455-20466, 2007. (Pubitemid 47100027)
5. Kim M, Carman CV and Springer TA: Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301: 1720-1725, 2003. (Pubitemid 37174365)
6. Montanez E, Ussar S, Schifferer M, Bösl M, Zent R, Moser M and Fässler R: Kindlin-2 controls bidirectional signaling of integrins. Genes Dev 22: 1325-1330, 2008. (Pubitemid 351717522)
7. An Z, Dobra K, Lock JG, Strömblad S, Hjerpe A and Zhang H: Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration. Int J Cancer 127: 1999-2008, 2010.
8. Gong X, An Z, Wang Y, et al: Kindlin-2 controls sensitivity of prostate cancer cells to cisplatin-induced cell death. Cancer Lett 299: 54-62, 2010.
9. Kato K, Shiozawa T, Mitsushita J, et al: Expression of the mitogen-inducible gene-2 (mig-2) is elevated in human uterine leiomyomas but not in leiomyosarcomas. Hum Pathol 35: 55-60, 2004. (Pubitemid 38133923)
10. Sgambato A and Cittadini A: Inflammation and cancer: a multi-faceted link. Eur Rev Med Pharmacol Sci 14: 263-268, 2010.
11. Hagemann T, Balkwill F and Lawrence T: Inflammation and cancer: a double-edged sword. Cancer Cell 12: 300-301, 2007. (Pubitemid 47539316)
12. Mukhtar RA, Nseyo O, Campbell MJ and Esserman LJ: Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn 11: 91-100, 2011.
13. Zhang BC, Gao J, Wang J, Rao ZG, Wang BC and Gao JF: Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma. Med Oncol 28: 1447-1452, 2011.
14. Ohno S, Ohno Y, Suzuki N, et al: Correlation of histological localization of tumor-associated macrophages with clinico-pathological features in endometrial cancer. Anticancer Res 24: 3335-3342, 2004. (Pubitemid 39390949)
15. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N and Nomura Y: Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7: 263-269, 2000. (Pubitemid 30440592)
16. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996. (Pubitemid 26338061)
17. Fujimoto H, Sangai T, Ishii G, et al: Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer 125: 1276-1284, 2009.
18. Koga F, Kageyama Y, Kawakami S, et al: Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer. J Urol 171: 1080-1084, 2004. (Pubitemid 38327531)
19. Rajkumar T, Vijayalakshmi N, Gopal G, Sabitha K, Shirley S, Raja UM and Ramakrishnan SA: Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int 10: 45, 2010.
20. Jackson CB, Judd LM, Menheniott TR, et al: Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 213: 140-151, 2007. (Pubitemid 47612236)
21. Won HH, Kim JW, Kim MJ, Kim S, Park JH and Lee KA: Interleukin 10 polymorphisms differentially influence the risk of gastric cancer in East Asians and Caucasians. Cytokine 51: 73-77, 2010.
22. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002. (Pubitemid 35223554)
23. Lewis C and Murdoch C: Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 167: 627-635, 2005. (Pubitemid 41216349)
24. Culig Z: Cytokine disbalance in common human cancers. Biochim Biophys Acta 1813: 308-314, 2011.
25. Savage SA, Abnet CC, Mark SD, et al: Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 13: 2251-2257, 2004. (Pubitemid 40054325)
26. Waugh D and Wilson C: The interleukin-8 pathway in cancer, Clin Cancer Res 14: 6735-6741, 2008.
27. Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonelrs A and Poovorawan Y: Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 12: 4473-4477, 2006. (Pubitemid 44256332)
28. Szaflarska A, Szczepanik A, Siedlar M, Czupryna A, Sierzega M, Popiela T and Zembala M: Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Anticancer Res 29: 5005-5012, 2009.
29. Paul SR, Bennett F, Calvetti JA, et al: Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87: 7512-7516, 1990. (Pubitemid 20341746)
30. Du X and Williams DA: Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89: 3897-3908, 1997. (Pubitemid 27220932)
31. Nakayama T, Yoshizaki A, Izumida S, et al: Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int J Oncol 30: 825-833, 2007.
32. Okano F and Yamada K: Canine interleukin-18 induces apoptosis and enhances Fas ligand mRNA expression in a canine carcinoma cell line. Anticancer Res 20: 3411-3415, 2000.
33. Coughlin CM, Salhany KE, Wysocka M, et al: Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 101: 1441-1452, 1998. (Pubitemid 28145262)
34. Cho D, Song H, Kim YM, et al: Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res 60: 2703-2709, 2000. (Pubitemid 30318247)
35. Lissoni P, Brivio F, Rovelli F, et al: Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced-secretion in metastatic disease. J Biol Regul Homeost Agents 14: 275-277, 2000. (Pubitemid 32124116)